Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.49SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBL.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FR.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.17SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.2.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HK.3.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.28SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
P.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
P.2 (Zeta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.33SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
N.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.499SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
N.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.212SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.16.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JF.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EG.5.1.13SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JG.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JN.1.13SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.16.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.62SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GW.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HH.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.22.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GY.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HW.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FY.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.38SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.16.12SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.46SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GB.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.72SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FY.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FY.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.2.3.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FE.1.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FY.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EG.1.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.1.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.16.30SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HH.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HK.29SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FY.3.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.2.3.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.24SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.2.3.20SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EG.5.2.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HK.27SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HK.30SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HK.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used